• FirefoxInstall the new Firefox »
  •  Dow Down 0.93% Nasdaq Down 0.53%

    More On ASTM

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Vericel Corporation (ASTM)

    -NasdaqCM
    2.77 Down 0.03(0.90%) Nov 24 - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.77
    Open:2.77
    Bid:N/A
    Ask:N/A
    1y Target Est:4.88
    Beta:1.76
    Next Earnings Date:N/A
    Day's Range:2.76 - 2.85
    52wk Range:2.76 - 21.00
    Volume:42,450
    Avg Vol (3m):204,135
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-3.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ASTMDown 0.90%N/A
    BAXDown 1.10%37.14B
    CYTXDown 0.86%106.32M
    JNJDown 1.57%280.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aastrom Biosciences, Inc., a clinical-stage biotechnology company, focuses on the development of cell therapies for use in the treatment of severe chronic ischemic cardiovascular diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback